Adjuvant Chemotherapy in Colon Cancer: Simple is Better… Less is More

Adjuvant Chemotherapy in Colon Cancer: Simple is Better… Less is More

A significant number of patients with colorectal cancer (CRC) benefit from adjuvant therapy. While 6 months of FOLFOX is standard of care, newer regimens like CAPOX and SOX allow for shorter durations. Trials of importance include SCOT (U.K., Denmark, Spain, Sweden, Australia, New Zealand), TOSCA (I...

Full description

Saved in:

Bibliographic Details
Main Authors:	Prasad Narayanan, Shyam Aggarwal, Manish Singhal, Vamshi Krishna, A. K. Rathi, Brig H. P. Singh, Atul Sharma, J. B. Sharma, Amit Bhargava, P. Suresh, Meenu Walia, H. S. Darling, K. Medhi, Kumardeep Dutta, Sajjan Singh Rajpurohit, Prashant Mehta, Vikas Goswami, Saumitra Rawat, C. Selvasekar, Purvish M. Parikh
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2024-10-01
Series:	South Asian Journal of Cancer
Subjects:	overall survival toxicity drug metabolism geriatric patients ctDNA MRD
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1802564
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC Consortium
by: Andrew G. Hadd, et al.
Published: (2025-03-01)

The utilisation of ctDNA approaches for residual disease detection during neoadjuvant and perioperative immunotherapy in oesophagogastric cancers
by: Ronan J. Kelly, et al.
Published: (2025-02-01)

Dynamic circulating tumor DNA indicates pathological benefits of additional neoadjuvant chemoimmunotherapy courses for locally advanced non-small-cell lung cancer patients
by: Dong Lin, et al.
Published: (2025-07-01)

Beyond traditional biopsies: the emerging role of ctDNA and MRD on breast cancer diagnosis and treatment
by: Hussein Sabit, et al.
Published: (2025-03-01)

Circulating tumor DNA fraction predicts residual cancer burden post-neoadjuvant chemotherapy in triple negative breast cancer
by: Naing Lin Shan, et al.
Published: (2024-12-01)

Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker studyResearch in context
by: Lissa Wullaert, et al.
Published: (2025-09-01)

False-Positive and False-Negative MRD Results in Children with Acute Lymphoblastic Leukemia: Navigating Between Scylla and Charybdis (Brief Review and Clinical Experience)
by: Yulia S. Korkina, et al.
Published: (2025-06-01)

Management of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in a Jehovah’s Witness using chemotherapy free regimen: A case report and review of literature
by: Muhammad Hassan Raza, et al.
Published: (2025-01-01)

Plasma-based transcriptomic non-coding signature for predicting relapse in pediatric acute lymphoblastic leukemia
by: Yaping Wang, et al.
Published: (2024-12-01)

Frontalis sling surgery - pediatric versus adult population: characteristics and outcomes
by: Roee Arnon, et al.
Published: (2024-12-01)

Real-World Efficacy and Safety of Gemtuzumab Ozogamycin (GO) and 3 + 7 regimen in fit newly diagnosed Acute Myeloid Leukemia (AML) patients. A Retrospective multicenter study of “Rete Ematologica Pugliese” (REP)
by: M. Dargenio, et al.
Published: (2025-01-01)

Minimal Residual Disease Detection: Implications for Clinical Diagnosis and Cancer Patient Treatment
by: Meiling Song, et al.
Published: (2025-06-01)

Research trends and hotspots of circulating tumor DNA in colorectal cancer: a bibliometric study
by: Lele Zhang, et al.
Published: (2025-05-01)

No evidence of leukaemia (NEL) as a response criteria in paediatric AML: a multicentre analysisResearch in context
by: Evangelia Antoniou, et al.
Published: (2025-06-01)

Predicting Disease Progression in Inoperable Localized NSCLC Patients Using ctDNA Machine Learning Model
by: Yuqi Wu, et al.
Published: (2024-10-01)

Very early remission and increased apoptosis with the use of Pentoxifylline in children with acute lymphoblastic leukemia
by: Violeta Salceda-Rivera, et al.
Published: (2024-10-01)

Functional analysis of the Escherichia coli mrdA gene in melittin resistance
by: Chong-Yi Zhao, et al.
Published: (2025-03-01)

Combinatory Flowcytometric Approach in Pediatric Acute Lymphoid Leukemia Identifies Surrogate Minimal Residual Disease Markers
by: Noreen Grace George, et al.
Published: (2025-03-01)

Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumors
by: J. Abraham, et al.
Published: (2025-07-01)

Non‐Invasive Tumor‐Naïve Minimal Residual Disease Detection of Liver Cancer by Incorporating Circulating Tumor DNA Features and Alpha‐Fetoprotein: A Prospective Study
by: Qingqi Ren, et al.
Published: (2024-12-01)

Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuum
by: Jodie Wong, et al.
Published: (2025-02-01)

Prenatal diagnosis of intellectual disability, autosomal dominant 29 with a nonsense pathogenic variant in SETBP1: a case report and literature review
by: Zhuo Wei, et al.
Published: (2025-03-01)

Key predictors of long-term outcomes in BCMA-targeted CAR-T therapy for relapsed/refractory multiple myeloma
by: Ning An, et al.
Published: (2025-05-01)

Circulating Tumor DNA (ctDNA) in Kidney Cancer: A Narrative Review
by: Wesley Yip, et al.
Published: (2023-07-01)

Familial Polyposis and Colon Cancer
by: Amit Kumar Jain, et al.
Published: (2024-10-01)

A Novel Intronic Mutation in MBD5 Results in Autosomal Dominant Intellectual Disability Type 1 due to Abnormal Splicing
by: Heng Jiang, et al.
Published: (2025-07-01)

Transanal Minimally Invasive Surgery for Rectal Cancer
by: Sheikh Mohammad Taha Mustafa, et al.
Published: (2024-10-01)

Detection of oncogenic fusions in colorectal cancer using a partner-agnostic next-generation sequencing approach
by: Andrew J. Pellatt, et al.
Published: (2025-07-01)

Exploring the Clinical Value of Perioperative ctDNA‐Based Detection of Molecular Residual Disease in Patients With Esophageal Squamous Cell Carcinoma
by: Jimin Li, et al.
Published: (2025-02-01)

Clinical features and outcomes of patients with acute myeloid leukemia: the single-center experience of 668 patients in China
by: Jie Ding, et al.
Published: (2024-12-01)

Circulating tumor DNA profiling for non-invasive genomic analysis in Indian lung cancer patients: A real-world experience
by: Prerana Jha, et al.
Published: (2025-06-01)

Revolution of Circulating Tumor DNA: From Bench Innovations to Bedside Implementations
by: Xuehan Yan, et al.
Published: (2025-06-01)

The Application of Circulating Tumour DNA (ctDNA) in the Diagnosis, Prognosis, and Treatment Monitoring of Gynaecological and Breast Cancers (Review)
by: Aleksandra Englisz, et al.
Published: (2025-05-01)

Clinical trial and real-world evidence of circulating tumor DNA monitoring to predict recurrence in patients with resected colorectal cancer
by: H.T. Nguyen, et al.
Published: (2024-12-01)

Correlative Analysis of Tumor-Informed Circulating Tumor DNA (ctDNA) and the Survival Outcomes of Patients with Pancreatic Adenocarcinoma
by: Yuqi Zhang, et al.
Published: (2025-05-01)

Different mutations in TBL1XR1 lead to diverse phenotypes of neurodevelopmental disorder: two case reports
by: Linlin Wei, et al.
Published: (2025-05-01)

Longitudinal Tracking of ALK-Rearranged NSCLC From Plasma Using Circulating Tumor RNA and Circulating Tumor DNA
by: Simon Heeke, PhD, et al.
Published: (2025-04-01)

In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibition
by: Isabel Heidrich, et al.
Published: (2025-07-01)

Utility of Germline, Somatic and ctDNA Testing in Adults With Cancer
by: Emily DeBortoli, et al.
Published: (2025-08-01)

Multimodal Framework in Lung Cancer Management: Integrating Liquid Biopsy with Traditional Diagnostic Techniques
by: Qi W, et al.
Published: (2025-03-01)